We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+23.95%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.74B
AUM Growth
+$946M
Cap. Flow
+$105M
Cap. Flow %
1.56%
Top 10 Hldgs %
63.65%
Holding
393
New
188
Increased
79
Reduced
42
Closed
65

Top Buys

Rank Stock Value
1
XRAY icon
Dentsply Sirona
XRAY
+$76M
2
NVO
Novo Nordisk
NVO
+$43.1M
3
FRPT icon
Freshpet
FRPT
+$41.5M
4
SBUX icon
Starbucks
SBUX
+$31.9M
5
BMY icon
Bristol-Myers Squibb
BMY
+$30.3M

Top Sells

Rank Stock Value
1
SUPN icon
Supernus Pharmaceuticals
SUPN
+$79.6M
2
PTCT icon
PTC Therapeutics
PTCT
+$76M
3
GRFS
Grifois
GRFS
+$50.6M
4
STAA icon
STAAR Surgical
STAA
+$47.2M
5
TVTX icon
Travere Therapeutics
TVTX
+$40.5M

Sector Composition

Rank Sector Weight
1 Healthcare 31.9%
2 Technology 5.53%
3 Consumer Discretionary 5.27%
4 Communication Services 2.01%
5 Consumer Staples 1.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TXN icon
301
Texas Instruments
TXN
$261B
$219K ﹤0.01%
+1,191
New +$233K
PLD icon
302
Prologis
PLD
$133B
$218K ﹤0.01%
+1,900
New +$209K
KAI icon
303
Kadant
KAI
$3.99B
$216K ﹤0.01%
+725
New +$237K
AGX icon
304
Argan
AGX
$8.37B
$215K ﹤0.01%
+796
New +$182K
NCNO icon
305
nCino
NCNO
$2.1B
$214K ﹤0.01%
+7,876
New +$230K
KEX icon
306
Kirby Corp
KEX
$6.93B
$208K ﹤0.01%
+2,490
New +$250K
FMC icon
307
FMC
FMC
$1.33B
$204K ﹤0.01%
+6,077
New +$237K
SU icon
308
Suncor Energy
SU
$70.3B
$204K ﹤0.01%
+4,877
New +$196K
NTR icon
309
Nutrien
NTR
$30.7B
$202K ﹤0.01%
+3,447
New +$201K
LVS icon
310
Las Vegas Sands
LVS
$29.6B
$201K ﹤0.01%
+3,729
New +$196K
FLY
311
Firefly Aerospace
FLY
$4.39B
$201K ﹤0.01%
+6,839
New +$307K
GBDC icon
312
Golub Capital BDC
GBDC
$3.42B
$187K ﹤0.01%
+13,692
New +$202K
NXGLW icon
313
NexGel Inc Warrant
NXGLW
$165K ﹤0.01%
550,000
– –
BEATW icon
314
Heartbeam Inc Warrant
BEATW
$41.3K
$156K ﹤0.01%
500,000
– –
KYIV
315
Kyivstar Group
KYIV
$3.09B
$154K ﹤0.01%
+12,301
New +$146K
DGNX
316
Diginex Ltd
DGNX
$44.2M
$144K ﹤0.01%
+1,250
New +$83.4K
COLD icon
317
Americold
COLD
$4.27B
$140K ﹤0.01%
+11,427
New +$170K
STLA icon
318
Stellantis
STLA
$20.8B
$121K ﹤0.01%
+12,984
New +$124K
REVB icon
319
Revelation Biosciences
REVB
$4.46M
$114K ﹤0.01%
+20,000
New +$194K
ONFOW icon
320
Onfolio Holdings Warrant
ONFOW
$64.5K
$99.9K ﹤0.01%
400,000
– –
SNAP icon
321
Snap
SNAP
$9.01B
$99.3K ﹤0.01%
+12,881
New +$107K
MDCXW
322
Medicus Pharma Warrant
MDCXW
$434K
$43.6K ﹤0.01%
60,600
– –
SWAGW icon
323
Stran & Company Warrant
SWAGW
$66.4K
$36.1K ﹤0.01%
545,000
– –
RVSNW icon
324
Rail Vision Ltd Warrant
RVSNW
$725K
$12.8K ﹤0.01%
136,187
– –
SQFTW icon
325
Presidio Property Trust Inc Series A Warrants
SQFTW
$217K
$7.48K ﹤0.01%
200,000
– –
11 12
13
14 15

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q3 2025 Portfolio in Review

As of Q3 2025, Armistice Capital held 393 positions worth $6.74B, up 16% from $5.8B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Armistice Capital's Q3 2025 filing shows 188 new, 79 increased, 42 reduced and 65 closed positions. Its largest new stake was Novo Nordisk: 736,000 shares worth $40.8M. The largest sale was Supernus Pharmaceuticals, an estimated $79.6M.

By sector, the portfolio is most concentrated in Healthcare at 32% of assets, up from 31% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Armistice Capital's largest Q3 2025 buy was Novo Nordisk: 736,000 shares worth $40.8M.
  • Armistice Capital added most to Dentsply Sirona in Q3 2025, an estimated $76M increase.
  • Armistice Capital's biggest Q3 2025 reduction was Supernus Pharmaceuticals, cutting an estimated $79.6M.
  • Armistice Capital fully exited STAAR Surgical in Q3 2025, selling an estimated $47.2M.
  • Armistice Capital's ten largest holdings make up 64% of its $6.74B portfolio in Q3 2025.
  • Armistice Capital opened 188 new positions and closed 65 in Q3 2025.
  • Armistice Capital's portfolio value rose 16% quarter-over-quarter to $6.74B.

Based on Armistice Capital's 13F filing for Q3 2025, filed 17 Nov 2025.